News

States that do provide coverage have tried to manage costs by putting prescribing limits on the GLP-1s. There’s also some ...
U.S. states are struggling to manage rising costs of GLP-1 drugs like Wegovy and Ozempic, which are popular for weight loss.
States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound ... are among their concerns.The debate over coverage coincides with rising ...
States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching ... potential side effects are among their concerns.The debate over ...
WASHINGTON — States increasingly struggling to cover the rising cost of popular GLP-1 drugs ... 60 pounds." The debate over coverage coincides with rising Medicaid budgets and the prospect ...